Cargando…
TRIM14 is a Putative Tumor Suppressor and Regulator of Innate Immune Response in Non-Small Cell Lung Cancer
Non-small-cell lung carcinoma (NSCLC) accounts for 85% of malignant lung tumors and is the leading cause of cancer deaths. Our group previously identified Tripartite Motif 14 (TRIM14) as a component of a prognostic multigene expression signature for NSCLC. Little is known about the function of TRIM1...
Autores principales: | Hai, Josephine, Zhu, Chang-Qi, Wang, Tao, Organ, Shawna L., Shepherd, Frances A., Tsao, Ming-Sound |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216374/ https://www.ncbi.nlm.nih.gov/pubmed/28059079 http://dx.doi.org/10.1038/srep39692 |
Ejemplares similares
-
Substrate recognition by TRIM and TRIM-like proteins in innate immunity
por: Wang, Hai-Tao, et al.
Publicado: (2021) -
p120RasGAP Is a Mediator of Rho Pathway Activation and Tumorigenicity in the DLD1 Colorectal Cancer Cell Line
por: Organ, Shawna L., et al.
Publicado: (2014) -
To TRIM the Immunity: From Innate to Adaptive Immunity
por: Yang, Wenyong, et al.
Publicado: (2020) -
Lipocalin2 Promotes Invasion, Tumorigenicity and Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma
por: Leung, Lisa, et al.
Publicado: (2012) -
TRIM25 in the Regulation of the Antiviral Innate Immunity
por: Martín-Vicente, María, et al.
Publicado: (2017)